Solid Biosciences Inc. SLDB Payments Of Common Stock And Pre Funded Warrants Issuance Costs In Public Offering
Payments Of Common Stock And Pre Funded Warrants Issuance Costs In Public Offering at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept sldb:PaymentsOfCommonStockAndPreFundedWarrantsIssuanceCostsInPublicOffering.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s payments of common stock and pre funded warrants issuance costs in public offering.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solid Biosciences Inc.'s payments of common stock and pre funded warrants issuance costs in public offering?
- Solid Biosciences Inc. (SLDB) reported payments of common stock and pre funded warrants issuance costs in public offering of $0 in Q1 2026.
- How has Solid Biosciences Inc.'s payments of common stock and pre funded warrants issuance costs in public offering changed year-over-year?
- Solid Biosciences Inc.'s payments of common stock and pre funded warrants issuance costs in public offering decreased by 100.0% year-over-year, from $20K to $0.
- What does payments of common stock and pre funded warrants issuance costs in public offering mean?
- This represents the direct costs incurred in the process of executing a public equity offering, such as legal, accounting, and underwriting fees. It quantifies the friction costs associated with raising capital. Investors monitor this to evaluate the efficiency of the company's capital-raising activities.